Vivos Therapeutics, Inc. (VVOS) Analyst Estimates Quarterly - Discounting Cash Flows
VVOS
Vivos Therapeutics, Inc.
VVOS (NASDAQ)
Period Ending: 2026
12-30
2026
09-30
2026
06-30
2026
03-30
2025
12-30
2025
09-30
2025
06-30
2025
03-30
2024
12-30
2024
09-30
2024
06-30
2024
03-30
2023
12-30
2023
09-29
2023
06-29
2023
03-29
2022
12-29
2022
09-29
2022
06-29
2022
03-29
2021
12-29
2021
09-29
2021
06-29
2021
03-29
2020
12-29
Number of Analysts
1234
2 3 1 1 1 1 1 2 2 1 1 1 1 1 1 1 1 1 1 1 1
Estimated Revenue
Low
1234
6.36 4.07 3.06 3.33 3.53 3.8 3.27 3.32 3.21 4.08 3.73 3.63 4.13 3.37 3.55 4.02 4.39 4.08 3.26 2.95 2.91
Average
1234
6.45 4.71 3.36 3.67 3.89 4.18 3.6 3.41 3.41 4.5 4.12 4.01 4.55 3.72 3.92 4.44 4.85 4.5 3.6 3.25 3.21
High
1234
6.54 5.98 3.67 4 4.24 4.56 3.93 3.5 3.6 4.92 4.5 4.38 4.98 4.07 4.29 4.86 5.31 4.92 3.94 3.56 3.51
Estimated EBITDA
Low
1234
-5.97 -5.46 -3.35 -3.65 -3.87 -4.16 -3.58 -3.19 -3.28 -4.49 -4.11 -4 -4.55 -3.71 -3.91 -4.43 -4.84 -3.59 -3.75 -3.25 -3.2
Average
1234
-5.88 -4.3 -3.07 -3.35 -3.55 -3.81 -3.29 -3.11 -3.11 -4.11 -3.76 -3.66 -4.16 -3.4 -3.57 -4.05 -4.43 -2.99 -3.13 -2.97 -2.93
High
1234
-5.8 -3.71 -2.79 -3.04 -3.22 -3.47 -2.99 -3.03 -2.93 -3.72 -3.4 -3.31 -3.77 -3.08 -3.24 -3.67 -4.01 -2.39 -2.5 -2.69 -2.65
Estimated EBIT
Low
1234
-6.09 -5.57 -3.42 -3.72 -3.95 -4.25 -3.66 -3.26 -3.35 -4.58 -4.19 -4.08 -4.64 -3.79 -3.99 -4.53 -4.94 -4.04 -3.96 -3.31 -3.27
Average
1234
-6 -4.39 -3.13 -3.41 -3.62 -3.89 -3.35 -3.18 -3.17 -4.19 -3.83 -3.73 -4.24 -3.47 -3.65 -4.14 -4.52 -3.36 -3.3 -3.03 -2.99
High
1234
-5.92 -3.79 -2.85 -3.1 -3.29 -3.54 -3.05 -3.09 -2.99 -3.8 -3.47 -3.38 -3.84 -3.14 -3.31 -3.75 -4.09 -2.69 -2.64 -2.74 -2.71
Estimated Net Income
Low
1234
-5.93 -5.8 -4.66 -4.9 -4.84 -8.03 -12.87 -13.1 -22.64 -36.91 -44.6 -55.36 -67.66 -76.89 -76.89 -79.96 -76.89 -4 -3.94 -52.28 -50.75
Average
1234
-5.3 -5.59 -4.17 -4.39 -4.33 -7.18 -11.51 -12.88 -20.89 -32.89 -39.74 -49.34 -60.3 -68.52 -68.52 -71.26 -68.52 -3.33 -3.28 -46.6 -45.22
High
1234
-4.67 -5.27 -3.67 -3.87 -3.82 -6.33 -10.15 -12.77 -19.24 -28.87 -34.89 -43.31 -52.94 -60.16 -60.16 -62.56 -60.16 -2.67 -2.63 -40.91 -39.7
Estimated SGA Expenses
Low
1234
10.83 6.93 5.21 5.68 6.02 6.47 5.57 5.65 5.46 6.94 6.35 6.18 7.03 5.74 6.04 6.85 7.48 6.94 5.56 5.02 4.95
Average
1234
10.98 8.02 5.73 6.24 6.62 7.12 6.13 5.81 5.8 7.66 7.01 6.82 7.76 6.34 6.67 7.56 8.26 7.66 6.13 5.54 5.46
High
1234
11.13 10.19 6.25 6.81 7.22 7.77 6.69 5.96 6.12 8.38 7.67 7.46 8.48 6.93 7.3 8.28 9.04 8.38 6.71 6.06 5.98
Estimated EPS
Low
1234
-0.54 -0.529 -0.425 -0.447 -0.442 -0.732 -1.17 -1.2 -2.07 -3.37 -4.07 -5.05 -6.17 -7.01 -7.01 -7.29 -7.01 -5.19 -5.05 -4.77 -4.63
Average
1234
-0.483 -0.51 -0.38 -0.4 -0.395 -0.655 -1.05 -1.18 -1.91 -3 -3.62 -4.5 -5.5 -6.25 -6.25 -6.5 -6.25 -4.62 -4.5 -4.25 -4.12
High
1234
-0.426 -0.481 -0.335 -0.353 -0.348 -0.578 -0.926 -1.16 -1.75 -2.63 -3.18 -3.95 -4.83 -5.49 -5.49 -5.71 -5.49 -4.06 -3.95 -3.73 -3.62
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program